Header

UZH-Logo

Maintenance Infos

Epilepsie im Kindesalter: Wann kann die antiepileptische Therapie abgesetzt werden?


Schmitt, Bernhard; Albani, Michael; Bast, Thomas; Brandl, Ulrich; Korinthenberg, Rudolf; Kurlemann, Gerhard; Neubauer, Bernd; Stephani, Ulrich; Wolff, Markus (2007). Epilepsie im Kindesalter: Wann kann die antiepileptische Therapie abgesetzt werden? Zeitschrift für Epileptologie, 20(3):113-119.

Abstract

The Königsteiner Arbeitskreis (KA) discussed the optimal timing of discontinuation of antiepileptic drugs (AE) in children. Because the controlled trials are rare and inconsistent it was decided to publish the results of the discussion and the approach of the KA members. In neonates AE are usually withdrawn within 2-12 weeks after the last seizure. In infantile spasms, vigabatrin is discontinued 6-12 and sulthiam 6-36 months after the cessation of spasms. After steroids the majority of the KA members continue AE for 2 years. For Rolandic epilepsy 1-3 seizurefree years seem to be sufficient to stop AE, even when focal spike waves persist. In symptomatic focal epilepsy the decision of discontinuation is influenced by the underlying disease. In absence epilepsy AE are discontinued after 2 years; whereas in myoclonic astatic epilepsy most members prefer 2-5 seizure-free years before AE are tapered. Agreement exists about the high risk of relapse after withdrawal of AE in juvenile myoclonic epilepsy and the majority of the members never stop AE in patients with this syndrome. Some KA members however, consider discontinuation after 2-3 seizure-free years. With respect to the rate of withdrawal, most members prefer a slow (3-12 months) tapering. Rapid (< 3 months) tapering is practised only by 2 KA members. The role of EEG for the decision of AE discontinuation is limited to some epileptic syndromes (i.e. absence epilepsy). The paper reflects the opinion of the KA and is not feasible as a guideline. The decision to discontinue AE is always an individual decision based on the underlying disease, the kind of epilepsy and the psychosocial circumstances of the patient

Abstract

The Königsteiner Arbeitskreis (KA) discussed the optimal timing of discontinuation of antiepileptic drugs (AE) in children. Because the controlled trials are rare and inconsistent it was decided to publish the results of the discussion and the approach of the KA members. In neonates AE are usually withdrawn within 2-12 weeks after the last seizure. In infantile spasms, vigabatrin is discontinued 6-12 and sulthiam 6-36 months after the cessation of spasms. After steroids the majority of the KA members continue AE for 2 years. For Rolandic epilepsy 1-3 seizurefree years seem to be sufficient to stop AE, even when focal spike waves persist. In symptomatic focal epilepsy the decision of discontinuation is influenced by the underlying disease. In absence epilepsy AE are discontinued after 2 years; whereas in myoclonic astatic epilepsy most members prefer 2-5 seizure-free years before AE are tapered. Agreement exists about the high risk of relapse after withdrawal of AE in juvenile myoclonic epilepsy and the majority of the members never stop AE in patients with this syndrome. Some KA members however, consider discontinuation after 2-3 seizure-free years. With respect to the rate of withdrawal, most members prefer a slow (3-12 months) tapering. Rapid (< 3 months) tapering is practised only by 2 KA members. The role of EEG for the decision of AE discontinuation is limited to some epileptic syndromes (i.e. absence epilepsy). The paper reflects the opinion of the KA and is not feasible as a guideline. The decision to discontinue AE is always an individual decision based on the underlying disease, the kind of epilepsy and the psychosocial circumstances of the patient

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Downloads

1 download since deposited on 06 Dec 2018
1 download since 12 months
Detailed statistics

Additional indexing

Other titles:Childhood epilepsy: When to discontinue antiepileptic therapy
Item Type:Journal Article, refereed, original work
Communities & Collections:National licences > 142-005
Dewey Decimal Classification:610 Medicine & health
Language:German
Date:1 August 2007
Deposited On:06 Dec 2018 16:41
Last Modified:06 Dec 2018 16:41
Publisher:Springer
ISSN:1610-0646
OA Status:Green
Publisher DOI:https://doi.org/10.1007/s10309-007-0258-9
Related URLs:https://www.swissbib.ch/Search/Results?lookfor=nationallicencespringer101007s1030900702589 (Library Catalogue)

Download

Download PDF  'Epilepsie im Kindesalter: Wann kann die antiepileptische Therapie abgesetzt werden?'.
Preview
Content: Published Version
Language: German
Filetype: PDF (Nationallizenz 142-005)
Size: 207kB
View at publisher